Why a New Cancer Drug Works Well, In Some Patients

摘要: A new drug called gefitinib (Iressa) has given cancer patients a glimmer of hope, while presenting puzzle: Iressa causes significant tumor shrinkage in only about 10% the who take it, but when it does work, clinicians say, works amazingly well. Results published online by Science on 29 April provide an explanation for why is so much more effective some than others.